Data as of Jul 25
| +0.61 / +5.97%|
The 9 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 22.00 and a low estimate of 14.00. The median estimate represents a +38.50% increase from the last price of 10.83.
The current consensus among 9 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.